Interferon- -2b in the treatment of acute hepatitis C

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1315, 2001-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEG-Interferon Alfa-2b for Acute Hepatitis C: A Review

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-08 ,pp. : 839-843

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C

By Jansen Peter LM De Bruijne Joep

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Interferon- -2b/ribavirin vs monotherapy in hepatitis C

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 322, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite